Litmus Health said yesterday that it launched its clinical data science platform into public beta. The company hopes to use big data from wearables and connected devices to help inform endpoints for Phase I & II clinical trials.
The goal of its platform, according to Litmus, is to get pharmaceuticals to market faster by putting health-related quality of life as the primary motivation for clinical development. Massive sets of data collected from wearables will help to inform researchers about their patients quality of life outside the clinic.
Get the full story at our sister site, Drug Delivery Business News.
The post Litmus Health looks to bring wearables to drug development appeared first on MassDevice.
from MassDevice http://ift.tt/2eUCsKA
Cap comentari:
Publica un comentari a l'entrada